While we have shown that the downregulation of SR-BI in breast cancer cell lines is associated with reduced cellular cholesterol content and reduced tumor aggressivity (Danilo et al., 2013), it remains to be determined whether SR-BI-regulated signaling pathways and cholesterol homeostasis can be uncoupled. Here, SCARB1 is linked to breast cancer.